Pfizer

Its efforts to stop the virus have attracted attention…

The industry may have earned itself a grace period…

If the dollar tanks, you’ll want to be ready…

Watch as Marc reveals his process…

It’s never been more important to be selective…

We closed out a 228% gain…

Biotech stocks can be potent choices for investors, but it’s important to be a good judge of their potential.

There are opportunities for biotech investors to profit at each stage of clinical trials.

Pfizer’s struggles with free cash flow and dividend cuts may have a silver lining if its growth meets expectations.